Literature DB >> 32026669

Clinical predictors and significance of adherent perinephric fat assessed with Mayo Adhesive Probability (MAP) score and perinephric fat surface density (PnFSD) at the time of partial nephrectomy for localized renal mass. A single high-volume referral center experience.

Fabrizio DI Maida1, Gianni Vittori1, Riccardo Campi1, Andrea Mari1, Riccardo Tellini1, Simone Sforza1, Francesco Sessa1, Silvia Lucarini2, Vittorio Miele2, Linda Vignozzi3, Lorenzo Masieri1, Marco Carini1, Andrea Minervini4.   

Abstract

BACKGROUND: Adherent perinephric fat (APF) could negatively influence surgical outcomes of partial nephrectomy (PN). Novel radiological scores have been introduced to preoperatively detect APF, i.e. Mayo Adhesive Probability (MAP) score and perinephric fat surface density (PnFSD). We aimed to evaluate clinical predictors of APF and the association of MAP and PnFSD with perioperative outcomes after PN.
METHODS: Clinical and radiological data of patients undergoing open or robotic PN were prospectively gathered. Perinephric fat was retrospectively measured by a single expert uro-radiologist. Patients were divided into MAP 0-3 vs. MAP 4-5 and high vs. low PnFSD. Multivariable analysis was performed to seek for clinical predictors of APF.
RESULTS: Overall, 175 patients were entered. Patients with vs. without APF were significantly different regarding age, gender, ASA score, Charlson Comorbidity Index, Body Mass Index, waist circumference, HDL status and metabolic syndrome. Conversely, tumor-related characteristics were not significantly different between the groups. At multivariable analysis, metabolic syndrome was confirmed as the only independent predictor of APF (OR: 24.9; P<0.001). Notably, APF assessed by MAP score or PnFSD was not associated with perioperative outcomes after PN.
CONCLUSIONS: In experienced hands, APF did not impact on intra- or perioperative outcomes after PN. Metabolic syndrome was the only significant predictor of APF in our series.

Entities:  

Year:  2020        PMID: 32026669     DOI: 10.23736/S0393-2249.20.03698-X

Source DB:  PubMed          Journal:  Minerva Urol Nephrol        ISSN: 2724-6051


  4 in total

1.  Study on the correlation between preoperative inflammatory indexes and adhesional perinephric fat before laparoscopic partial nephrectomy.

Authors:  Teng Ma; Lin Cong; Qianli Ma; Zhaoqin Huang; Qianqian Hua; Xiaojiao Li; Ximing Wang; Yunchao Chen
Journal:  BMC Urol       Date:  2021-12-10       Impact factor: 2.264

2.  Predictors of Positive Surgical Margins after Robot-Assisted Partial Nephrectomy for Localized Renal Tumors: Insights from a Large Multicenter International Prospective Observational Project (The Surface-Intermediate-Base Margin Score Consortium).

Authors:  Fabrizio Di Maida; Riccardo Campi; Brian R Lane; Ottavio De Cobelli; Francesco Sanguedolce; Georgios Hatzichristodoulou; Alessandro Antonelli; Antonio Andrea Grosso; Sabrina Noyes; Oscar Rodriguez-Faba; Frank X Keeley; Johan Langenhuijsen; Gennaro Musi; Tobias Klatte; Marco Roscigno; Bulent Akdogan; Maria Furlan; Claudio Simeone; Nihat Karakoyunlu; Martin Marszalek; Umberto Capitanio; Alessandro Volpe; Sabine Brookman-May; Jürgen E Gschwend; Marc C Smaldone; Robert G Uzzo; Alexander Kutikov; Andrea Minervini
Journal:  J Clin Med       Date:  2022-03-23       Impact factor: 4.241

3.  Development of a simple nomogram to estimate risk for intraoperative complications before partial nephrectomy based on the Mayo Adhesive Probability score combined with the RENAL nephrometry score.

Authors:  Xiaojun Tan; Dachun Jin; Jian Hu; Weili Zhang; Yu Zhou; Yunxiang Li; Yuanfeng Zhang; Ji Wu
Journal:  Investig Clin Urol       Date:  2021-07

4.  Open and Laparoscopic Partial Nephrectomy: Comparison and Validation of Preoperative Scoring Systems, Including PADUA, RENAL, ABC Nephrometric Scores and Perinephric Fat Evaluation with Mayo Adhesive Probability Score.

Authors:  Maxime Sempels; Mohamed Ali Ben Chehida; Paul Meunier; David Waltregny
Journal:  Res Rep Urol       Date:  2021-07-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.